Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Voorham (Singapore, Singapore), N. Roche (Paris, France), J. Stephens (Swansia, United Kingdom), H. Park (Seoul, Republic of Korea), R. Fogel (East Hanover, United States of America), A. Clemens (Basel, Switzerland), G. Brusselle (Ghent, Belgium), D. Price (Singapore, Singapore). Association between ICS therapy for COPD and diabetes onset and progression. 5164

Member's Comments

No comment yet.

Related content which might interest you: Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus Source: International Congress 2017 – COPD management Year: 2017 Influence of statin therapy on exacerbation frequency in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 C-reactive protein at discharge, diabetes mellitus and ≥1 prior hospitalization predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Association of COPD inhaled  medication adherence with hospitalization for acute exacerbation of COPD (AECOPD) Source: International Congress 2017 – COPD management Year: 2017 Impact of diabetes in patients with COPD Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline Source: International Congress 2018 – COPD management Year: 2018 Diabetes and hospitalization for COPD exacerbation Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Long-term use of inhaled corticosteroids and the risk of type 2 diabetes in COPD Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Lung function in the patients with COPD and with the combination COPD and grownup's diabetes Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003 The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 The effect of statin therapy in patients with chronic obstructive airway disease Source: International Congress 2015 – COPD: notable points Year: 2015 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids Source: Annual Congress 2006 - COPD therapy Year: 2006 Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 Single inhaler triple therapy in advanced COPD patients: prior medication and disease severity FULFIL subanalyses Source: International Congress 2017 – COPD management Year: 2017